FI934701L - Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet - Google Patents

Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet Download PDF

Info

Publication number
FI934701L
FI934701L FI934701A FI934701A FI934701L FI 934701 L FI934701 L FI 934701L FI 934701 A FI934701 A FI 934701A FI 934701 A FI934701 A FI 934701A FI 934701 L FI934701 L FI 934701L
Authority
FI
Finland
Prior art keywords
neurotrofinaktivitet
analyssystem
detektering
eller
foer maetning
Prior art date
Application number
FI934701A
Other languages
English (en)
Finnish (fi)
Other versions
FI934701A7 (fi
FI934701A0 (fi
Inventor
Stephen P Squinto
David Glass
Thomas H Aldrich
Peter Distephano
Trevor Stitt
Mark E Furth
George D Yancopoulos
Peter C Maisonpierre
Piotr Masiakowski
Nancy Ip
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of FI934701A0 publication Critical patent/FI934701A0/fi
Publication of FI934701A7 publication Critical patent/FI934701A7/fi
Publication of FI934701L publication Critical patent/FI934701L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI934701A 1991-04-23 1992-04-23 Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet FI934701L (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69019991A 1991-04-23 1991-04-23
US73655991A 1991-07-26 1991-07-26
PCT/US1992/003376 WO1992018149A1 (fr) 1991-04-23 1992-04-23 Systemes d'analyse permettant de detecter l'activite de la neurotrophine

Publications (3)

Publication Number Publication Date
FI934701A0 FI934701A0 (fi) 1993-10-25
FI934701A7 FI934701A7 (fi) 1993-12-22
FI934701L true FI934701L (fi) 1993-12-22

Family

ID=27104557

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934701A FI934701L (fi) 1991-04-23 1992-04-23 Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet

Country Status (18)

Country Link
EP (2) EP0589961B1 (fr)
JP (1) JPH06509413A (fr)
AT (2) ATE214733T1 (fr)
AU (1) AU676664B2 (fr)
CA (1) CA2109100A1 (fr)
CZ (1) CZ223793A3 (fr)
DE (2) DE69233649D1 (fr)
DK (1) DK0589961T3 (fr)
ES (1) ES2170056T3 (fr)
FI (1) FI934701L (fr)
HU (1) HUT66051A (fr)
IE (1) IE921316A1 (fr)
IL (1) IL101661A (fr)
NO (1) NO933819L (fr)
NZ (1) NZ242468A (fr)
PT (1) PT100423A (fr)
SK (1) SK116593A3 (fr)
WO (1) WO1992018149A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109598A1 (fr) * 1991-05-21 1992-11-26 Finn Hallbook Methodes therapeutiques et diagnostiques basees sur l'expression de la neurotrophine 4
WO1993025684A1 (fr) * 1992-06-12 1993-12-23 Regeneron Pharmaceuticals, Inc. Procedes therapeutique et diagnostique bases sur l'expression de la neurotrophine-4
JPH07246040A (ja) * 1993-07-06 1995-09-26 Takeda Chem Ind Ltd ニューロトロフィン−3遺伝子が不活性化された胚幹細胞および該遺伝子発現不全動物
US5625121A (en) * 1993-09-02 1997-04-29 Bristol-Myers Squibb Company Mice deficient in nerve growth factor receptors encoded by trkB
US5753225A (en) 1993-12-03 1998-05-19 The Regents Of The University Of California Antibodies that mimic actions of neurotrophins
US6103689A (en) * 1994-08-31 2000-08-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6867179B1 (en) 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
EP0939829B1 (fr) * 1996-03-28 2008-08-20 Trustees Of Boston University Techniques de modulation de la synthese de la melanine
WO1997037228A1 (fr) * 1996-03-29 1997-10-09 The Trustees Of Boston University Procedes pour diagnostiquer et traiter la maladie d'alzheimer
GB9807781D0 (en) * 1998-04-09 1998-06-10 Univ Bristol Therapeutic agent
EP2789630A1 (fr) 2013-04-09 2014-10-15 EngMab AG Anticorps bispécifiques contre le CD3e et ROR1
EP3204415B1 (fr) 2014-10-09 2020-06-17 EngMab Sàrl Anticorps bispécifiques contre cd3epsilon et ror1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963481A (en) * 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
US5231001A (en) * 1991-03-14 1993-07-27 The United States Of America As Represented By The Department Of Health And Human Services Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
CA2062377A1 (fr) * 1991-03-21 1992-09-22 Mariano Barbacid Methode de detection de substances neuroactives
US5843749A (en) * 1991-07-26 1998-12-01 Regeneron Pharmaceuticals, Inc. Ehk and Ror tyrosine kinases

Also Published As

Publication number Publication date
NO933819D0 (no) 1993-10-22
JPH06509413A (ja) 1994-10-20
EP1001024B1 (fr) 2006-08-16
FI934701A7 (fi) 1993-12-22
IL101661A (en) 1998-02-08
ATE336576T1 (de) 2006-09-15
ES2170056T3 (es) 2002-08-01
ATE214733T1 (de) 2002-04-15
EP1001024A3 (fr) 2004-02-18
IL101661A0 (en) 1992-12-30
NO933819L (no) 1993-12-20
IE921316A1 (en) 1992-11-04
DK0589961T3 (da) 2002-05-27
EP1001024A2 (fr) 2000-05-17
CZ223793A3 (en) 1994-08-17
WO1992018149A1 (fr) 1992-10-29
HUT66051A (en) 1994-09-28
HU9303012D0 (en) 1994-03-28
DE69232496D1 (de) 2002-04-25
DE69232496T2 (de) 2002-10-10
EP0589961A1 (fr) 1994-04-06
CA2109100A1 (fr) 1992-10-29
HK1024935A1 (en) 2000-10-27
EP0589961A4 (fr) 1994-11-02
NZ242468A (en) 1994-12-22
EP0589961B1 (fr) 2002-03-20
FI934701A0 (fi) 1993-10-25
AU2014992A (en) 1992-11-17
PT100423A (pt) 1993-08-31
AU676664B2 (en) 1997-03-20
SK116593A3 (en) 1994-11-09
DE69233649D1 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
FI934849A7 (fi) Sammansaettningar foer foerhindrande och/eller behandlande av patologiskaprocesser
FI930258L (fi) Bestaoende vattenhaltiga dispersioner eller suspensioner av tryckresistenta gasfyllda mikrovesiklar och foerfarande foer framstaellning av dessa
FI922613L (fi) Blandningar av kedjeformiga och cykliska siloxaner eller siloxanoligomerer, foerfarande foer deras framstaellning och deras anvaendning
FI924999L (fi) Foerfarande och reagenser foer DNA-typning av HLA-klass I
FI923321L (fi) Komposition foer ihaollande och kontrollerad avgivning av medikamentartad aemne
FI933661A7 (fi) Reglering av en varm- och/eller kallvalsningsprocess
FI923654L (fi) Anordning och foerfarande foer loestagbart faestande av linsformstycken
FI925087L (fi) Foerfarande och behaollare foer sterilisering eller desinficering
FI925115L (fi) Vattenloesliga polymerer och/eller kopolymerer med baettre biologisk nedbrytningsfoermaoga och deras anvaendningar
FI922564A7 (fi) Foerfarande foer bestaemning av utjaemningsfoerdroejningar i oeverfoeringssystem och motsvarande oeverfoeringssystem
FI924493L (fi) Foerfarande och anordning foer insaettning av tryckeriprodukter i huvudprodukter
FI935190A0 (fi) Foerfarande och anordning foer bestaemning av totala stroemningen i en ventilationsinstallation
FI915577L (fi) Foerfarande och anordning foer torkning av braensle i en virvelbaeddspanna
FI922459L (fi) Foerfarande foer framstaellning av substituerade diaminoftalimider och deras analoger
FI921284L (fi) Framstaellnin av styva skum och komposition anvaendbar daeri
FI934569A7 (fi) Foerbaettrade retardsystem foer foerdroejd frigoering av medicinskt och/eller biologiskt verkande aemnen fraon depotbaerarmaterial
FI923761L (fi) Foerfarande foer framstaellning av soforosider medelst fermentering och under kontinuerlig tillfoersel av fettsyraestrar eller oljor
FI921769L (fi) Tvaettmedel foer minskning eller avlaegsning av zeolithalten
FI934701L (fi) Analyssystem foer maetning och/eller detektering av neurotrofinaktivitet
FI924363L (fi) Foerfarande foer behandling och/eller diagnostisering av mjukvaevnadstumoerer
FI932420A7 (fi) Fartygsskrov och drivsystem eller liknande
FI933947L (fi) Foerfarande foer braenning av svartlut i sodapannor och sodapanna foer braenning av svartlut
FI912260A7 (fi) Foerfarande och anordning foer belaeggning av roerligt underlag
FI932827A7 (fi) Anordning foer rengoerning och toemning av drycksvaetskeroer i tappningskranar
FI921318L (fi) Kopplingsanordning foer oemsesidig oeverfoering av data- och/eller styrsignaler

Legal Events

Date Code Title Description
FD Application lapsed